Transgene News and Research

RSS
Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Jennerex, Transgene present JX-594 Phase 1 and 2 study data in liver cancer at EASL meeting

Jennerex, Transgene present JX-594 Phase 1 and 2 study data in liver cancer at EASL meeting

First evidence of neurotrophic factors improving status of degenerating dopamine neurons in Parkinson's brains

First evidence of neurotrophic factors improving status of degenerating dopamine neurons in Parkinson's brains

Intrexon Corporation, ZIOPHARM enter partnership to develop, commercialize DNA-based therapeutics

Intrexon Corporation, ZIOPHARM enter partnership to develop, commercialize DNA-based therapeutics

Transposagen, CDI enter license agreement for iPS cell line production

Transposagen, CDI enter license agreement for iPS cell line production

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Simple protocol for determining Gross Chromosomal Rearrangement mutation rates

Simple protocol for determining Gross Chromosomal Rearrangement mutation rates

Maven Semantic announces updates to Bioinformatics medical professionals database

Maven Semantic announces updates to Bioinformatics medical professionals database

Epeius Biotechnologies announces Phase I/II study results of Rexin-G and Reximmune-C for cancer immunotherapy

Epeius Biotechnologies announces Phase I/II study results of Rexin-G and Reximmune-C for cancer immunotherapy

Sigma Life Science announces global release of CompoZr Targeted Integration Kit

Sigma Life Science announces global release of CompoZr Targeted Integration Kit

Techulon, UC sign worldwide exclusive license agreements to market Glycofect-Transfection Reagent

Techulon, UC sign worldwide exclusive license agreements to market Glycofect-Transfection Reagent

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

Donald Danforth Plant Science Center researchers enter into research collaboration with Dow AgroSciences

Donald Danforth Plant Science Center researchers enter into research collaboration with Dow AgroSciences

Prize4life partners with Jackson Laboratory on AML research

Prize4life partners with Jackson Laboratory on AML research

Scientists develop new model of skin cancer based on Src kinases

Scientists develop new model of skin cancer based on Src kinases

arGentis Pharmaceuticals to commence human clinical evaluation of ARG301 oral altered peptide ligand

arGentis Pharmaceuticals to commence human clinical evaluation of ARG301 oral altered peptide ligand